Treatment of Anemia in Lower-Risk Myelodysplastic Syndrome (vol 25, pg 752, 2024)

被引：0
|
作者：
Battaglia, Muriel R. [1 ]
Cannova, Joseph [2 ]
Madero-Marroquin, Rafael [2 ]
Patel, Anand A. [2 ]
机构：
[1] Univ Chicago, Dept Med, Chicago, IL USA
[2] Univ Chicago, Dept Med, Sect Hematol Oncol, 5841 S Maryland Ave MC 2115, Chicago, IL 60637 USA
来源：
CURRENT TREATMENT OPTIONS IN ONCOLOGY | 2024年
关键词：
D O I：
10.1007/s11864-024-01263-8
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1335 / 1335
页数：1
相关论文
共 50 条
  • [21] Eltrombopag in Lower-Risk Myelodysplastic Syndrome: Revival of Its Use in Thrombocytopenia
    Kulasekararaj, Austin G.
    Trikha, Roochi
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (28) : 4465 - +
  • [22] Validation of the 2016 revisions to the WHO classification in lower-risk myelodysplastic syndrome
    Kanagal-Shamanna, Rashmi
    Lopez, Juliana E. Hidalgo
    Milton, Denai R.
    Kim, Hye Ryoun
    Zhao, Chong
    Zuo, Zhuang
    Martinez, Michelle Janania
    Stingo, Francesco
    Lee, John
    Luthra, Rajyalakshmi
    Jabbour, Elias J.
    Garcia-Manero, Guillermo
    Medeiros, L. Jeffrey
    Bueso-Ramos, Carlos E.
    AMERICAN JOURNAL OF HEMATOLOGY, 2017, 92 (08) : E168 - E171
  • [23] Allogeneic Stem Cell Transplantation for Patients with Lower-Risk Myelodysplastic Syndrome
    Novak, Polona
    Zabelina, Tatjana
    Wolschke, Christine
    Ayuk, Francis
    Christopeit, Maximilian
    Kroeger, Nicolaus
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (11) : 2047 - 2052
  • [24] How to manage lower-risk myelodysplastic syndromes
    Sekeres, M. A.
    LEUKEMIA, 2012, 26 (03) : 390 - 394
  • [25] Luspatercept in Patients with Lower-Risk Myelodysplastic Syndromes
    Fenaux, Pierre
    Platzbecker, Uwe
    Mufti, Ghulam J.
    Garcia-Manero, Guillermo
    Buckstein, Rena
    Santini, Valeria
    Diez-Campelo, Maria
    Finelli, Carlo
    Cazzola, Mario
    Ilhan, Osman
    Sekeres, Mikkael A.
    Falantes, Jose F.
    Arrizabalaga, Beatriz
    Salvi, Flavia
    Giai, Valentina
    Vyas, Paresh
    Bowen, David
    Selleslag, Dominik
    DeZern, Amy E.
    Jurcic, Joseph G.
    Germing, Ulrich
    Goetze, Katharina S.
    Quesnel, Bruno
    Beyne-Rauzy, Odile
    Cluzeau, Thomas
    Voso, Maria-Teresa
    Mazure, Dominiek
    Vellenga, Edo
    Greenberg, Peter L.
    Hellstrom-Lindberg, Eva
    Zeidan, Amer M.
    Ades, Lionel
    Verma, Amit
    Savona, Michael R.
    Laadem, Abderrahmane
    Benzohra, Aziz
    Zhang, Jennie
    Rampersad, Anita
    Dunshee, Diana R.
    Linde, Peter G.
    Sherman, Matthew L.
    Komrokji, Rami S.
    List, Alan F.
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (02): : 140 - 151
  • [26] Lowering the boom on lower-risk myelodysplastic syndromes
    Sekeres, Mikkael A.
    Patel, Bhumika J.
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2019, : 367 - 372
  • [27] Evolving therapies for lower-risk myelodysplastic syndromes
    Bewersdorf, Jan Philipp
    Zeidan, Amer M.
    ANNALS OF HEMATOLOGY, 2020, 99 (04) : 677 - 692
  • [28] Management of patients with lower-risk myelodysplastic syndromes
    Andrew M. Brunner
    Heather A. Leitch
    Arjan A. van de Loosdrecht
    Nicolas Bonadies
    Blood Cancer Journal, 12
  • [29] Diagnostic algorithm for lower-risk myelodysplastic syndromes
    Mufti, Ghulam J.
    McLornan, Donal P.
    van de Loosdrecht, Arjan A.
    Germing, Ulrich
    Hasserjian, Robert P.
    LEUKEMIA, 2018, 32 (08) : 1679 - 1696
  • [30] Outcome of Patients with Lower-Risk Myelodysplastic Syndrome (MDS) After Azacitidine (AZA) Treatment Failure.
    Mishra, Asmita
    Lancet, Jeffrey E.
    Al Ali, Najla H.
    Padron, Eric
    Ho, Viet Q.
    Little, Bryan J.
    Pinilla-Ibarz, Javier
    List, Alan F.
    Komrokji, Rami S.
    BLOOD, 2012, 120 (21)
12345